S

02335

Shaanxi Micot Pharmaceutical Tec…

Upcoming IPOs
Listing Date: --
Filed
Offering
Price Range

Pending

Shares to be Issued

Pending

Offering End Date
Offering Price

Pending

Post IPO Outstanding

Pending

Listed
P/E (FWD)--
P/B--
P/S--
MARKET CAP--
INDUSTRY--
News
Press Releases
Financial Reports
Profile
    Same Industry
    Name/Symbol
    Change%
    Price

    昊海生物科技

    06826

    +1.60%
    16.560

    藥明康德

    02359

    -1.18%
    125.200

    泰格醫藥

    03347

    -1.04%
    32.280

    昭衍新藥

    06127

    -1.27%
    16.320

    康龍化成

    03759

    -2.19%
    15.180

    方達控股

    01521

    +3.00%
    1.030

    01035

    --

    08225

    --

    銘源醫療

    00233

    0.00%
    0.230

    08572

    --

    邁博藥業-B

    02181

    0.00%
    0.385

    維亞生物

    01873

    -2.56%
    1.140

    中國再生醫學

    08158

    -7.94%
    0.290

    01875

    --

    華領醫藥-B

    02552

    -0.85%
    2.320

    M

    MicroPort NeuroScientific

    02172

    +0.73%
    9.660

    康寧傑瑞製藥-B

    09966

    -1.27%
    7.010

    S

    SinoMab BioScience

    03681

    -6.98%
    1.200

    02157

    --

    01167

    --

    Contact Us

    Contact Number :+852 3852 8500
    Monday 7:00 AM - Saturday 9:00 AM (HKT)
    Service Email :service@webull.hk
    Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
    Business Cooperation :marketinghk@webull.hk
    Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
    Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
    Language

    English

    ©2026 Webull Securities Limited. All rights reserved.